HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Review. The origin of the prion agent of kuru: molecular and biological strain typing.

Abstract
Kuru is an acquired human prion disease that primarily affected the Fore linguistic group of the Eastern Highlands of Papua New Guinea. The central clinical feature of kuru is progressive cerebellar ataxia and, in sharp contrast to most cases of sporadic Creutzfeldt-Jakob disease (CJD), dementia is a less prominent and usually late clinical feature. In this regard, kuru is more similar to variant CJD, which also has similar prodromal symptoms of sensory disturbance and joint pains in the legs and psychiatric and behavioural changes. Since a significant part of the clinicopathological diversity seen in human prion disease is likely to relate to the propagation of distinct human prion strains, we have compared the transmission properties of kuru prions with those isolated from patients with sporadic, iatrogenic and variant CJD in both transgenic and wild-type mice. These data have established that kuru prions have prion strain properties equivalent to those of classical (sporadic and iatrogenic) CJD prions but distinct from variant CJD prions. Here, we review these findings and discuss how peripheral routes of infection and other factors may be critical modifiers of the kuru phenotype.
AuthorsJonathan D F Wadsworth, Susan Joiner, Jacqueline M Linehan, Emmanuel A Asante, Sebastian Brandner, John Collinge
JournalPhilosophical transactions of the Royal Society of London. Series B, Biological sciences (Philos Trans R Soc Lond B Biol Sci) Vol. 363 Issue 1510 Pg. 3747-53 (Nov 27 2008) ISSN: 1471-2970 [Electronic] England
PMID18849291 (Publication Type: Journal Article, Review)
Chemical References
  • Prions
Topics
  • Animals
  • Creutzfeldt-Jakob Syndrome (genetics)
  • Disease Transmission, Infectious
  • Immunoblotting
  • Kuru (genetics, pathology, transmission)
  • Mice
  • Mice, Transgenic
  • Papua New Guinea
  • Phenotype
  • Prions (classification, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: